Ability to generate synthetic peptides that immunologicaly mimic HIV-1 tat regulatory protein [1]

AIDS

Volumn 17, Issue 13, 2003, Pages 2001-2002

  Biquard, Jean Michel ^a   M'Bika, Jean Pierre ^b   Krsmanovic, Velibor ^c   Achour, Ammar ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; POLYPEPTIDE; SYNTHETIC PEPTIDE; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; VACCINATION; VIRUS INFECTION; VIRUS NEUTRALIZATION;

AIDS VACCINES; GENE PRODUCTS, TAT; HIV-1; HUMANS; IMMUNE SERA; MOLECULAR MIMICRY; PEPTIDES;

EID: 0043288590     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200309050-00026     Document Type: Letter

References (4)

1. Bisset LRÒ Molecular mimicry in the pathogenesis of AIDS: the HIV/MHC/mycoplasma triangle. Med Hypotheses 1994, 43:388-396.
2. Eisenberg D, Weiss RM, Terwilliger TC. The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature 1982, 299:371-374.
3. Krsmanovic V, Biquard JM, Sikorska-Walker M, Cosic I, Desgranges C, Trabaud MA, et al. Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins. J Pept Res 1998, 52:410-420.
4. Goldstein G. HIV-1 Tat protein as a potential AIDS vaccine. Nat Med 1996, 2:960-964.